
Join to view full profile
2010 W Chester PikeSte 407Havertown, PA 19083
Phone+1 610-853-2502
Fax+1 610-853-2507
Dr. Li is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Shanghai Jiao Tong University School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1994 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2011, 2013-2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 6 citationsTo use stroke 911 to improve stroke awareness for countries where 911 is used as an emergency phone number.Renyu Liu, Jing Zhao, Xiaobin Li, Steven Messe, Marc Fisher
CNS Neuroscience & Therapeutics. 2022-10-01 - 143 citationsMagnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?A. Pathmanathan, Nicholas van As, Linda G W Kerkmeijer, John Christodouleas, Colleen A. Lawton
International Journal of Radiation Oncology, Biology, Physics. 2018-02-01 - 31 citationsVariability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.Entesar Z. Dalah, I Moraru, Eric S. Paulson, Beth Erickson, X. Allen Li
International Journal of Radiation Oncology, Biology, Physics. 2014-07-01
Press Mentions
Penn Medicine Doctor’s Stroke Film Makes WHO Film Festival ShortlistApril 14th, 2022
Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin LymphomaDecember 1st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









